Azerbaijan vs Liberia: The number of people with susceptibility test result for rifampicin
Azerbaijan
1,409
in 2021
Liberia
1,486
in 2021
Azerbaijan rank
59th
Liberia rank
57th
The number of people with susceptibility test result for rifampicin over time
- Azerbaijan
- Liberia
How they compare
Liberia currently reports 1,486 against 1,409 in Azerbaijan, a difference of 77.
That makes Liberia's figure about 1.1 times Azerbaijan's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Azerbaijan ahead.
Azerbaijan ranks 59th and Liberia ranks 57th of 155 countries.
Azerbaijan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,956 | 1,172 | 783.67 | Azerbaijan |
| 2020s | 1,327 | 1,204 | 122.5 | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Azerbaijan or Liberia?
- Liberia, at 1,486 against 1,409 in Azerbaijan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Azerbaijan and Liberia?
- 77, with Liberia ahead.
- How many years of comparable data are there for Azerbaijan and Liberia?
- 5 years are reported by both, from 2017 to 2021.
- How do Azerbaijan and Liberia rank globally for the number of people with susceptibility test result for rifampicin?
- Azerbaijan ranks 59th and Liberia ranks 57th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.